122 related articles for article (PubMed ID: 486687)
1. Radioimmunoassay determination of two main cross-reacting viral antigens during radiation and Rauscher induced leukemias.
Sassen A; Vander Plaetse F; Janowski M; Maisin JR
Biomedicine; 1979 Jul; 30(3):147-55. PubMed ID: 486687
[TBL] [Abstract][Full Text] [Related]
2. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
Haran-Ghera N; Rubio N
J Immunol; 1977 Feb; 118(2):607-11. PubMed ID: 839072
[TBL] [Abstract][Full Text] [Related]
3. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
Varet B; Cannat A; Gisselbrecht S
Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
[TBL] [Abstract][Full Text] [Related]
5. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
Kaneko Y; Oettgen HF; Obata Y; Nakayama E
Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
[TBL] [Abstract][Full Text] [Related]
6. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
Haran-Ghera N; Ben-Yaakov M; Peled A
J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
[TBL] [Abstract][Full Text] [Related]
7. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical examination of soluble antigens in the serum of Balb/c mice infected with Rauscher leukaemia virus.
Tóth FD; Váczi L; Kása M; Karsai T
Acta Microbiol Acad Sci Hung; 1976; 23(2):185-90. PubMed ID: 61713
[TBL] [Abstract][Full Text] [Related]
9. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
[TBL] [Abstract][Full Text] [Related]
10. Serological analysis of immune response to friend virus-induced leukemia.
Ting CC; Herberman RB
Cancer Res; 1974 Jul; 34(7):1676-83. PubMed ID: 4134291
[No Abstract] [Full Text] [Related]
11. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
Ishimoto A; Ito Y
Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
[No Abstract] [Full Text] [Related]
12. [Biology, serology and biochemistry of leucemogenic viruses derived from a radiation-induced tumor of C57BL mice].
Janowski M; Baugnet-Mahiec L; Merregaert J; de Saint-Georges L; Sassen A; Ihle JN; Maisin JR
C R Seances Soc Biol Fil; 1980; 174(5):832-9. PubMed ID: 6159954
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface antigens induced by Friend and Rauscher virus complexes and their associated lymphatic leukemia viruses in the rat.
Kuzumaki N; Kobayashi H
Cancer Res; 1975 Jul; 35(7):1718-22. PubMed ID: 1131829
[TBL] [Abstract][Full Text] [Related]
14. Cell surface antigens reacting with antiretrovirus sera on normal mouse spleen cells: a flow cytometric study.
Szabó G; D-Tóth F; Réthy A
Cytometry; 1983 Jul; 4(1):47-53. PubMed ID: 6617393
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class.
Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y
J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622
[TBL] [Abstract][Full Text] [Related]
16. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of cellular immunity to Rauscher leukemia virus.
Mortensen RF; Ceglowski WS; Friedman H
J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
[No Abstract] [Full Text] [Related]
18. Reconstitution of the W/Wv stem cell differentiation defect by infection with Rauscher leukemia virus.
Merchav S; Wagemaker G; van Bekkum DW
J Natl Cancer Inst; 1985 Aug; 75(2):361-8. PubMed ID: 3894753
[TBL] [Abstract][Full Text] [Related]
19. Resistance to RadLV-induced leukemia: non-participation of splenic natural killer cells.
St-Pierre Y; Hugo P; Lemieux S; Lussier G; Potworowski EF
Leukemia; 1988 Aug; 2(8):551-3. PubMed ID: 2842550
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity to Friend virus-induced leukemia.
Ting CC; Shiu G; Rodrigues D; Herberman RB
Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
